C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/17/2002	US20020150979 Process for producing a protein
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150973 Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity
10/17/2002	US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002	US20020150969 Generating peptidyl prolyl cis-trans isomerases; obtain cell, transform with vector containing isomerase, express vector, evaluate activity of enzyme
10/17/2002	US20020150963 Map
10/17/2002	US20020150954 Detecting modulators of tumor suppressor gene activity; obtain cells, incubate with modulator, detec adjustment of gene expression from tumor suppressor gene, adjustment in activity indicates modulator
10/17/2002	US20020150953 Detecting modulators of muscle protein activity; obtain mixture of calcineurin and muscle protein, monitor binding, incubate with modulator, monitor adjustment in binding activity compare to control
10/17/2002	US20020150949 High throughput screening for novel enzymes
10/17/2002	US20020150946 Mammalian tolloid-like gene and protein
10/17/2002	US20020150945 Methods for making polynucleotide libraries, polynucleotide arrays, and cell libraries for high-throughput genomics analysis
10/17/2002	US20020150943 Genotyping by mass spectrometric analysis of allelic fragments
10/17/2002	US20020150942 Probe carrier and method of manufacturing the same
10/17/2002	US20020150941 Displaying gene expression in viable cells; obtain cells, generate three-dimensional image, display on screen, monitor screen for gene expression patterns
10/17/2002	US20020150940 Linear and circular expression elements
10/17/2002	US20020150937 Nucleic acid extraction solution and use thereof
10/17/2002	US20020150932 Computer-aided visualization of expression comparison
10/17/2002	US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002	US20020150928 Amplification preferential nucleotide sequences in sample; obtain sample nucleotide sequences, store in preservation fluid, drain fluid, recover nucleotide sequence amplify sequences, evaluate nucleotide sequences
10/17/2002	US20020150918 Method for detection of biological factors in epidermis
10/17/2002	US20020150917 Determining concentration of preferential nucleotide sequences in sample; obtain nucleotide sequences, amplify, hybridize with amplicons, detect and quantitate hybridization products
10/17/2002	US20020150916 43716, a novel human G-protein and uses thereof
10/17/2002	US20020150912 Expression vector for use as diagnostic tool in genetic engineering and analysis
10/17/2002	US20020150910 33410, a novel human carboxylesterase family member and uses thereof
10/17/2002	US20020150907 Screening for preferential cells in sample; obtain cell sample, lyse, adhere nucleic acids to filter, wash and elute nucleotide sequences, determine sequence concentration, determine cell abundance based on nucleic acid concentration
10/17/2002	US20020150904 Polynucleotide sequence assay
10/17/2002	US20020150903 Diagnostics based on mass spectrometry
10/17/2002	US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002	US20020150900 Materials and methods for detection of nucleic acids
10/17/2002	US20020150899 Generating preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences
10/17/2002	US20020150897 Method for detecting and isolating genes
10/17/2002	US20020150896 Diagnosis and treatment of diabetes; obtain nucleotide sequence sample from tissue, detect polymorphism, presence of polymorphsm indicates diabetes
10/17/2002	US20020150893 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
10/17/2002	US20020150889 Peptide for use in the detection of herpes virus infections
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150883 Immunoassays for anti-HCV antibodies using antigens with conformational epitopes
10/17/2002	US20020150881 Recovering nucleotide sequences coding preferential protein; obtain phage coding preferential protein, express protein, separate phage displaying binding domain, recover phage displaying chimeric binding protein on surface
10/17/2002	US20020150880 Detecting viral sequences in sample; obtain nucleotide sequences, incubate with primers, amplify, detect amplified target sequence
10/17/2002	US20020150669 Electrospraying apparatus and method for coating particles
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150588 Hybrid polypeptides; diagnosis, monitoring cancer
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150584 Animal feeds; pneumonia vaccine
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150572 Methods and compositions for the treatment of psoriasis
10/17/2002	US20020150571 Antibodies specific for native PrPSc
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150569 Using monoclonal antibodies
10/17/2002	US20020150562 Viral preparations, vectors, immunogens, and vaccines
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150558 Immobilization; viricides
10/17/2002	US20020150557 Viricides; medical diagnosis
10/17/2002	US20020150556 Antitumor agents
10/17/2002	US20020150555 Interleukins; osteoporosis therapy
10/17/2002	US20020150554 Chicken interleukin-15 and uses thereof
10/17/2002	US20020150551 Protease surface treatment
10/17/2002	US20020150541 Mixture of human interferons; viricides; anticancer agents; antiinflammatory agents;
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002	DE10162387A1 Für das rpoB-Gen kodierende Nukleotidsequenzen For the rpoB gene coding nucleotide sequences
10/17/2002	DE10119179A1 New nucleic acid, useful for diagnostic detection of fungal RNA, specifically from Aspergillus, in clinical samples by nucleic acid sequence-based amplification
10/17/2002	DE10116826A1 Nachweisverfahren für homologe Rekombinationsereignisse Detection method for homologous recombination
10/17/2002	DE10116788A1 Nichtpathogener bakterieller Poringen-Rezipientenstamm eines Mycolsäure-haltigen Bakteriums, Verfahren zu dessen Herstellung und dessen Verwendung Nonpathogenic bacterial porin-recipient strain of mycolic acid-containing bacteria, a process for its preparation and its use
10/17/2002	DE10116518A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae
10/17/2002	DE10107843A1 Identifying herbicides and plant growth regulators, from ability to inhibit specific genes, also use of these genes to prepare herbicide-resistant transgenic plants
10/17/2002	CA2794446A1 Uncoupled productive and catabolic host cell pathways
10/17/2002	CA2699611A1 Desaturase genes and uses thereof
10/17/2002	CA2698579A1 Desaturase genes and uses thereof
10/17/2002	CA2479780A1 Antisense calpain nucleotides and uses thereof
10/17/2002	CA2446886A1 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443795A1 A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof
10/17/2002	CA2443691A1 Thermoelectric device for dna genomic and proteonic chips and thermo-optical switching circuits
10/17/2002	CA2443654A1 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
10/17/2002	CA2443641A1 Antisense modulation of phospholipid scramblase i expresion
10/17/2002	CA2443516A1 Novel human kinases and polynucleotides encoding the same
10/17/2002	CA2443411A1 Overexpression of phosphoenolpyruvate carboxylase
10/17/2002	CA2443395A1 Kits and methods for assessing oxidative stress
10/17/2002	CA2443377A1 D-hydantoinase from ochrobactrum anthropi
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443364A1 Transgenic zebrafish models for neurodegenerative diseases
10/17/2002	CA2443341A1 Human gene critical to fertility
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443319A1 Novel human kinase and polynucleotides encoding the same
10/17/2002	CA2443303A1 Method for preparing and selecting antibodies
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443277A1 Interferon gamma polypeptide variants
10/17/2002	CA2443275A1 Improved gene expression
10/17/2002	CA2443264A1 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus
10/17/2002	CA2443145A1 Uncoupled productive and catabolic host cell pathways
10/17/2002	CA2443067A1 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	CA2443060A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002	CA2443039A1 Artificial chromosomes comprising ehv sequences
10/17/2002	CA2442939A1 Polynucleotide analysis using combinatorial pcr
10/17/2002	CA2442935A1 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
10/17/2002	CA2442911A1 Bioluminescent plants and methods of making same

1 ... 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 ... 4023